PI3K/Akt inhibitor partly decreases TNF-α-induced activation of fibroblast-like synoviocytes in osteoarthritis

被引:62
|
作者
Liu, Songyang [1 ]
Cao, Chenxi [1 ,2 ]
Zhang, Yujun [3 ,4 ]
Liu, Guangyu [1 ]
Ren, Weixia [3 ,4 ]
Ye, Yanqi [1 ]
Sun, Tiezheng [1 ]
机构
[1] Peking Univ, Peoples Hosp, Arthritis Clin & Res Ctr, Beijing 100044, Peoples R China
[2] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100044, Peoples R China
[3] Peking Univ, Peoples Hosp, Inst Clin Mol Biol, Beijing 100044, Peoples R China
[4] Peking Univ, Peoples Hosp, Cent Lab, Beijing 100044, Peoples R China
关键词
PI3K/Akt inhibitor; TNF-alpha; Cadherin-11; Osteoarthritis; Fibroblast-like synoviocytes; PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR; CADHERIN-11; ARTHRITIS; SYNOVITIS; PATHOLOGY; INFLAMMATION; PROGRESSION; EXPRESSION; MIGRATION; CELLS;
D O I
10.1186/s13018-019-1394-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: The Cadherin-11 and PI3K/Akt pathway are increasingly recognized as the potential therapeutic target of osteoarthritis (OA) synovitis. The study aimed to investigate the role of PI3K/Akt signaling pathway in the expression of Cadherin-11 and migration and invasive capacity of fibroblast-like synoviocytes (FLS) of OA patients under stimulation of TNF-alpha and to explore the effect of the PI3K/Akt inhibitor and Cadherin-11 antibody in the therapy of the collagenase-induced osteoarthritis (CIOA) mice. Methods: FLS were primarily cultured from synovium of osteoarthritic patients during total knee arthroplasty. Under the simulation of TNF-alpha, with or without PI3K/Akt inhibitor LY294002, Cadherin-11 expression was detected by real-time PCR and Western blot, as well as the migration and invasive capacity changes of OA FLS. Cadherin-11 antibody was injected intraarticularly or LY294002 was injected intraperitoneally in CIOA mice to evaluate the changes of synovitis score, cartilage damage, and Cadherin-11 expression. Results: TNF-alpha stimulation increased Cadherin-11 expression at mRNA and protein level in OA FLS and also increased the phosphorylation-dependent activation of Akt. PI3K inhibitor LY294002 attenuated TNF-alpha-induced overexpression of Cadherin-11 and decreased the invasive capacity of OA FLS. Intraperitoneal injection of PI3K inhibitor LY294002 could decrease the Cadherin-11 protein expression in synovium of CIOA mice, although it has no significant inhibitory effect on synovitis and cartilage damage. Intraarticular injection of Cadherin-11 antibody attenuated the synovitis and cartilage damage in the CIOA joints and decreased Cadherin-11 expression in the synovial lining. Conclusions: PI3K/Akt pathway was associated with TNF-alpha-induced activation of OA FLS, which may involve in the pathogenesis of osteoarthritis. Anti-Cadherin-11 therapy in CIOA mice could attenuate the pathological changes of OA joints.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] Clusterin exacerbates interleukin-1β-induced inflammation via suppressing PI3K/Akt pathway in human fibroblast-like synoviocytes of knee osteoarthritis (vol 12, 9963, 2022)
    Ungsudechachai, Tachatra
    Honsawek, Sittisak
    Jittikoon, Jiraphun
    Udomsinprasert, Wanvisa
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [12] MicroRNA-21-5p are involved in apoptosis and invasion of fibroblast-like synoviocytes through PTEN/PI3K/AKT signal
    Xin Yan
    Yake Liu
    Xaoli Kong
    Juan Ji
    Hai Zhu
    Zexu Zhang
    Ting Fu
    Junling Yang
    Zhongyuan Zhang
    Fan Liu
    Zhifeng Gu
    Cytotechnology, 2019, 71 : 317 - 328
  • [13] BMP9 inhibits the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via the PI3K/AKT signaling pathway
    Song, Biao
    Li, Xiao-Feng
    Yao, Yao
    Xu, Qing-Qing
    Meng, Xiao-Ming
    Huang, Cheng
    Li, Jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 74
  • [14] Wogonin inhibits the migration and invasion of fibroblast-like synoviocytes by targeting PI3K/AKT/NF- κ B pathway in rheumatoid arthritis
    Yang, Haixin
    Liu, Cuizhen
    Lin, Xiujuan
    Li, Xing
    Zeng, Shan
    Gong, Zhaohui
    Xu, Qiang
    Li, Detang
    Li, Nan
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 755
  • [15] MicroRNA-21-5p are involved in apoptosis and invasion of fibroblast-like synoviocytes through PTEN/PI3K/AKT signal
    Yan, Xin
    Liu, Yake
    Kong, Xaoli
    Ji, Juan
    Zhu, Hai
    Zhang, Zexu
    Fu, Ting
    Yang, Junling
    Zhang, Zhongyuan
    Liu, Fan
    Gu, Zhifeng
    CYTOTECHNOLOGY, 2019, 71 (01) : 317 - 328
  • [16] Ferroportin inhibits the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via regulating ROS/PI3K/AKT signaling pathway
    Shao, Weiting
    Liu, Fanxiao
    Zhu, Lin
    Qian, Weiyi
    Meng, Qianqian
    Zhang, Afei
    Jin, Shuai
    Lu, Jingtao
    Yan, Shuang G.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 987
  • [17] Activation of fibroblast-like synoviocytes by T cells is TNFα dependent.
    Tran, Chinh N.
    Endres, Judith L.
    Fox, David A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S509 - S509
  • [18] Peroxiredoxin 4 regulates tumor-cell-like characteristics of fibroblast-like synoviocytes in rheumatoid arthritis through PI3k/Akt signaling pathway
    Aihaiti, Yirixiati
    Tuerhong, Xiadiye
    Zheng, Haishi
    Cai, YongSong
    Yang, Mingyi
    Xu, Peng
    CLINICAL IMMUNOLOGY, 2022, 237
  • [19] uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis
    Liu, Yan
    Pan, Yun Feng
    Xue, You-qiu
    Fang, Lin-kai
    Guo, Xing-hua
    Guo, Xin
    Liu, Meng
    Mo, Bi-yao
    Yang, Meng-ru
    Liu, Fang
    Wu, Yun-ting
    Olsen, Nancy
    Zheng, Song Guo
    CELLULAR & MOLECULAR IMMUNOLOGY, 2018, 15 (02) : 171 - 181
  • [20] Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-α-induced activation of fibroblast-like synoviocytes
    Jia, Qian
    Che, Qincheng
    Zhang, Xiaoyu
    Chen, Jie
    Ren, Chunfeng
    Wu, Yunpeng
    Liang, Weiqiang
    Zhang, Xiaojie
    Li, Yanshan
    Li, Zunzhong
    Zhang, Zhenchun
    Shu, Qiang
    BIOCHEMICAL PHARMACOLOGY, 2024, 220